Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma

From the Centre for the Study of Liver Disease and the Departments of Surgery (RT-PP, KK-CN, C-ML, S-TF) and Radiology (VA, JY), The University of Hong Kong, Pokfulam, Hong Kong, China.

Address correspondence and reprint requests to: Ronnie Tung-Ping Poon, MS, FRCS (Edin), FACS, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China; Fax: 852-28-17-5475.

	Abstract

Background: Limited data from recent studies suggested an increased risk of bleeding complications, needle-track seeding, and local recurrence after radiofrequency ablation (RFA) of subcapsular hepatocellular carcinoma (HCC).

Methods: Between May 2001 and October 2002, 80 patients underwent RFA of 104 HCC nodules. Forty-eight patients had subcapsular HCC (group I), whereas the other 32 patients did not have subcapsular HCC (group II). RFA was performed via celiotomy, laparoscopy, or a percutaneous approach. Subcapsular HCCs were ablated by indirect puncture through nontumorous liver, and the needle track was thermocoagulated.

Results: There were no significant differences between groups in treatment morbidity (14.6% vs. 15.6%; P = .898), mortality (2.1% vs. 0%; P = 1.000), complete ablation rate after a single session (89.4% vs. 96.9%; P = .392), local recurrence rate (4.3% vs. 12.5%; P = .216), recurrence-free survival (1 year: 60.9% vs. 49.2%; P = .258), or overall survival (1 year: 88.3% vs. 79.4%; P = .441). After a median follow-up of 13 months, no needle-track seeding or intraperitoneal metastasis was observed.

Conclusions: This study shows that the results of RFA for subcapsular HCCs are comparable to those of RFA for nonsubcapsular HCCs. Subcapsular HCC should not be considered a contraindication for RFA treatment.

Key Words: Hepatocellular carcinoma, Radiofrequency ablation, Complications, Subcapsular carcinoma

This article has been cited by other articles:

				S. Sartori, P. Tombesi, F. Macario, I. Nielsen, D. Tassinari, M. Catellani, and V. Abbasciano Subcapsular Liver Tumors Treated with Percutaneous Radiofrequency Ablation: A Prospective Comparison with Nonsubcapsular Liver Tumors for Safety and Effectiveness Radiology, August 1, 2008; 248(2): 670 - 679. [Abstract] [Full Text] [PDF]

				S. K. Kei, H. Rhim, D. Choi, W. J. Lee, H. K. Lim, and Y.-s. Kim Local Tumor Progression After Radiofrequency Ablation of Liver Tumors: Analysis of Morphologic Pattern and Site of Recurrence Am. J. Roentgenol., June 1, 2008; 190(6): 1544 - 1551. [Abstract] [Full Text] [PDF]

				Y. J. Kim, S. S. Raman, N. C. Yu, R. W. Busuttil, M. Tong, and D. S. K. Lu Radiofrequency Ablation of Hepatocellular Carcinoma: Can Subcapsular Tumors Be Safely Ablated? Am. J. Roentgenol., April 1, 2008; 190(4): 1029 - 1034. [Abstract] [Full Text] [PDF]

				S. N. Wong, C.-J. Lin, C.-C. Lin, W.-T. Chen, I. H. Y. Cua, and S.-M. Lin Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations Am. J. Roentgenol., March 1, 2008; 190(3): W187 - W195. [Abstract] [Full Text] [PDF]

				R. T. P. Poon, C. Lau, R. Pang, K. K. Ng, J. Yuen, and S. T. Fan High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies Ann. Surg. Oncol., June 1, 2007; 14(6): 1835 - 1845. [Abstract] [Full Text] [PDF]

				H. W. Head, G. D. Dodd III, N. C. Dalrymple, S. R. Prasad, F. M. El-Merhi, M. W. Freckleton, and L. G. Hubbard Percutaneous Radiofrequency Ablation of Hepatic Tumors against the Diaphragm: Frequency of Diaphragmatic Injury Radiology, June 1, 2007; 243(3): 877 - 884. [Abstract] [Full Text] [PDF]

				S. Mulier, Y. Ni, L. Frich, F. Burdio, A. L. Denys, J.-F. De Wispelaere, B. Dupas, N. Habib, M. Hoey, M. C. Jansen, et al. Experimental and Clinical Radiofrequency Ablation: Proposal for Standardized Description of Coagulation Size and Geometry Ann. Surg. Oncol., April 1, 2007; 14(4): 1381 - 1396. [Abstract] [Full Text] [PDF]

				R. T. P. Poon Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection? Ann. Surg. Oncol., February 1, 2007; 14(2): 541 - 547. [Abstract] [Full Text] [PDF]

				Y. K. Cho, H. Rhim, Y. S. Ahn, M. Y. Kim, and H. K. Lim Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S269 - S274. [Abstract] [Full Text] [PDF]

				E. K. Abdalla and J.-N. Vauthey Editorial: Technique and Patient Selection, Not the Needle, Determine Outcome of Percutaneous Intervention for Hepatocellular Carcinoma Ann. Surg. Oncol., March 1, 2004; 11(3): 240 - 241. [Full Text] [PDF]